Home
Conditions
Locally Advanced

Clinical trial condition

Locally Advanced

Explore clinical trials studying Locally Advanced. Study availability and eligibility vary by location and protocol.

27 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Locally Advanced trial results

Recruiting

Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

NCT07155850

Conditions: Locally Advanced, Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable
Locations: Fondazione Policlinico Universitario A. Gemelli, IRCCS Roma, Italy

Guy's & St Thomas' and Kings College Hospitals London, United Kingdom

View Trial Details

Recruiting

Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

NCT05679674

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States

View Trial Details

Recruiting

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

NCT06102057

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany

Universitätsklinikum Essen - Klinik für Strahlentherapie Essen, Germany

Medical Center - University Of Freiburg, Department of Radiation Oncology Freiburg im Breisgau, Germany

Universitätsmedizin Göttingen, Department for Radiotherapy and Radiooncology Göttingen, Germany

View Trial Details

Recruiting

SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer

NCT05576480

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, None Selected, China

View Trial Details

Recruiting

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

NCT05766800

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Shanghai Pulmonary Hospital Shanghai, China

View Trial Details

Recruiting

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

NCT06020430

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer

NCT06120387

Conditions: Locally Advanced, Urothelial Carcinoma Ureter
Locations: Departmeng of Urology, Peking University First Hospital Beijing, China

Department of Radiotherapy Oncology, Peking University First Hospital Beijing, China

View Trial Details

Recruiting

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer

NCT05877573

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Nanfang Hospital Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer

NCT05802394

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Not yet recruiting

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

NCT07046780

Conditions: Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Locally Advanced

Locally Advanced trial results

Related conditions